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Abstract
Background: Nicotine is a psychoactive drug presenting a diverse array of biological activities,
some positive, such as enhancement of cognitive performances, others negative, such as addiction
liability. Ligands that discriminate between the different isotypes of nicotinic acetylcholine
receptors (nAChRs) could present improved pharmacology and toxicity profile.
Results: Based on the recent crystal structure of a soluble acetylcholine binding protein from
snails, we have built atomic models of acetylcholine and nicotine bound to the pocket of four
different human nAChR subtypes. The structures of the docked ligands correlate with available
biochemical data, and reveal that the determinants for isotype selectivity are relying essentially on
four residues, providing diversity of the ligand binding pocket both in terms of Van der Waals
boundary, and electrostatic potential. We used our models to screen in silico a large compound
database and identify a new ligand candidate that could display subtype selectivity.
Conclusion: The nAChR-agonist models should be useful for the design of nAChR agonists with
diverse specificity profiles.
Background
The nicotinic acetylcholine receptor (nAChR) is a ligand-
gated ion channel that mediates neurotransmission at the
neuromuscular junction, autonomic ganglia and at some
sites in the central nervous system. Distinct nAChR sub-
types exist that can be stimulated by the neurotransmitter
acetylcholine, the natural product nicotine, or by synthet-
ic compounds [1]. nAChR is the prototype for a protein
superfamily that includes the receptors for the excitatory
amino acids glutamate and aspartate, the inhibitory ami-
no-acids gamma-aminobutyric acid (GABA) and glycine,
as well as the serotonin 5-HT3 receptor [1]. Like most lig-
and-gated ion channels, nAChRs are homo- or hetero-
pentameric, each monomer belonging to a pull of 8 al-
pha- or 3 beta-subunits (alpha2-9, beta2-4). While each
subunit has four transmembrane domains, the agonist
binding sites are located at the subunit interfaces [2]. Both
natural and synthetic ligands can display varied affinity
for different receptor subtypes. For instance, nicotine has
a Kd of 1 nM for alpha4-beta2 nAChR, but only 4 µM for
the alpha7-alpha7 isoform [3].
In recent years, it has become clear that the neuronal
nAChR is a valid target against a variety of diseases, in-
cluding cognitive and attention deficits, Parkinson's dis-
ease, anxiety, and pain management [3,4]; the addiction
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BMC Structural Biology 2002, 2 http://www.biomedcentral.com/1472-6807/2/1Figure 1
Multiple sequence alignment of AChBP with nAChR monomers. The alignment was divided into subunit 1 monomers (alpha3,
alpha4, alpha7) (top) and subunit 2 monomers (beta2, beta4, and alpha7) (bottom), in order to preserve separate residue
numbering consistent with human alpha4 and beta2 nAChR. Side-chain residues contacting docked acetylcholine and nicotine
are colored gold in subunit 1 and cyan in subunit 2. Additional residues forming the ligand binding pocket boundary but further
from the ligands are shown in bold. Non-conserved residues that can be used to design isotype selective agonists are under-
lined, and marked by a "!" in the numbering line. AChBP residues contacting HEPES in the crystal structure of the complex [6]
have a shaded background. Secondary structure elements are shown under the sequences : H=alpha helix, E = beta-strand,
B=beta-bridge.
                  30        40           60        70        80        90 
# Consensus    ~.   ..##.~.....RP   #.~.~.##.#.#~#.#.~##.V~E.~~.#~..#W.... 
alpha4        AEERLLKKLFSGYNKWSRP---VANISDVVLVRFGLSIAQLIDVDEKNQMMTTNVWVKQE 
alpha2        -EDRLFKHLFRGYNRWARP---VPNTSDVVIVRFGLSIAQLIDVDEKNQMMTTNVWLKQE 
alpha3        -EHRLFERLFEDYNEIIRP---VANVSDPVIIHFEVSMSQLVKVDEVNQIMETNLWLKQI 
alpha7        FQRKLYKELVKNYNPLERP---VANDSQPLTVYFSLSLLQIMDVDEKNQVLTTNIWLQMS 
AChBP         FDR---ADILYNIRQTSRPDVIPTQRDRPVAVSVSLKFINILEVNEITNEVDVVFWQQTT 
              _______HHHHHHHHH___   __B__B_EEEEEEEEE_EE_EEE____EEEEEEEEEEE 
 
                    100       110       120       130       140       150 
# Consensus   W~D..L.W~.^~..  ..#.#P.~.#W.PD###YN.#.....#~......#. ~G...%. 
alpha4        WHDYKLRWDPADYENVTSIRIPSELIWRPDIVLYNNADGDFAVTHLTKAHLFHDGRVQWT 
alpha2        WSDYKLRWNPADFGNITSLRVPSEMIWIPDIVLYNNADGEFAVTHMTKAHLFSTGTVHWV 
alpha3        WNDYKLKWNPSDYGGAEFMRVPAQKIWKPDIVLYNNAVGDFQVDDKTKALLKYTGEVTWI 
alpha7        WTDHYLQWNVSEYPGVKTVRFPDGQIWKPDILLYNSADERFDATFHTNVLVNSSGHCQYL 
AChBP         WSDRTLAWNSSHSP--DQVSVPISSLWVPDLAAYNAISKPEVLTPQLARVVS-DGEVLYM 
              EE_GGG___GGG_____EEEEEGGG_____EEE__B____EE____EEEEEGGG_EEEE_ 
 
                    160       170        180 !     190       200        210 
# Consensus   P....+.SC  DV..#..- ..~C.#K#GSW~~~..  ~#....~..~..~%#.~ ^.#. 
alpha4        PPAIYKSSCSIDVTFFPFD-QQNCTMKFGSWTYDKAKIDLVNMHSRVDQLDFWES-GEWV 
alpha2        PPAIYKSSCSIDVTFFPFD-QQNCKMKFGSWTYDKAKIDLEQMEQTVDLKDYWES-GEWA 
alpha3        PPAIFKSSCKIDVTYFPFD-YQNCTMKFGSWSYDKAKIDLVLIGSSMNLKDYWES-GEWA 
alpha7        PPGIFKSSCYIDVRWFPFD-VQHCKLKFGSWSYGGW--SLDLQMQEADISGYIPN-GEWD 
AChBP         PSIRQRFSC--DVSGVDTESGATCRIKIGSWTHHSREISVDPTTENSDDSEYFSQYSRFE 
              _EEEEEEE___________ _EEEEEEEEE_______EEEE______________ __EE 
 
                      220       230       240     
# Consensus   ##.#.~..~~..Y~CC.E#Y.D#~..#.#R+.. 
alpha4        IVDAVGTYNTRKYECCAEIYPDITYAFVIRRLP 
alpha2        IVNATGTYNSKKYDCCAEIYPDVTYAFVIRRLP 
alpha3        IIKAPGYKHDIKYNCCEEIYPDITYSLYIRRLP 
alpha7        LVGIPGKRSERFYECCKEPYPDVTFTVTMRRRT 
AChBP         ILDVTQKKNSVTYSCCPEAYEDVEVSLNFRKKG 
              E_EEEEEEEEEE______EEEEEEEEEEEEE__ 
                30        40           50        60        70        80  ! 
# Consensus   .~.   .~##.  ......RP   #.~.~.##.#.#.#.##~##~V~E.~~.#~..#W.. 
beta2         TEERLVEHLLDPSRYNKLIRP---ATNGSELVTVQLMVSLAQLISVHEREQIMTTNVWLT 
beta4         AEEKLMDDLLNKTRYNNLIRP---ATSSSQLISIKLQLSLAQLISVNEREQIMTTNVWLK 
alpha7        FQRKLYKELVK--NYNPLERP---VANDSQPLTVYFSLSLLQIMDVDEKNQVLTTNIWLQ 
AChBP         FDR---ADILY--NIRQTSRPDVIPTQRDRPVAVSVSLKFINILEVNEITNEVDVVFWQQ 
              ______________HHHH___   __B__B_EEEEEEEEE_EE_EEE____EEEEEEEEE 
 
                   90       100       110       120       130   !   140  ! 
# Consensus   .~W~D..L.W..~...  ..#.#P...#W.PD###YN. ~....#~#~...#V. ~G~.. 
beta2         QEWEDYRLTWKPEEFDNMKKVRLPSKHIWLPDVVLYNNADGMYEVSFYSNAVVSYDGSIF 
beta4         QEWTDYRLTWNSSRYEGVNILRIPAKRIWLPDIVLYNN-DGTYEVSVYTNLIVRSNGSVL 
alpha7        MSWTDHYLQWNVSEYPGVKTVRFPDGQIWKPDILLYNSADERFDATFHTNVLVNSSGHCQ 
AChBP         TTWSDRTLAWNSSHSP--DQVSVPISSLWVPDLAAYNAISKPEVLTPQLARVVS-DGEVL 
              EEEE_GGG___GGG_____EEEEEGGG_____EEE__B____EE____EEEEE____EEE 
  
                  150       160        170        180      190       200 
# Consensus   %#P....+.^C  -V..#..- ..~C.#K#.SW~~~..  ~#.#....^~.~~%..~ ^. 
beta2         WLPPAIYKSACKIEVKHFPFD-QQNCTMKFRSWTYDRTEIDLVLKSEVASLDDFTPS-GE 
beta4         WLPPAIYKSACKIEVKYFPFD-QQNCTLKFRSWTYDHTEIDMVLMTPTASMDDFTPS-GE 
alpha7        YLPPGIFKSSCYIDVRWFPFD-VQHCKLKFGSWSYGGW--SLDLQMQEADISGYIPN-GE 
AChBP         YMPSIRQRFSC--DVSGVDTESGATCRIKIGSWTHHSREISVDPTTENSDDSEYFSQYSR 
              E__EEEEEEE___________ _EEEEEEEEE_______EEEE______________ __ 
  
                    210          220       230 
# Consensus   #-##.#.~++~...~~   ..Y.D#~.~#.#+++. 
beta2         WDIVALPGRRNENPDD---STYVDITYDFIIRRKP 
beta4         WDIVALPGRRTVNPQD---PSYVDVTYDFIIKRKP 
alpha7        WDLVGIPGKRSERFYECCKEPYPDVTFTVTMRRRT 
AChBP         FEILDVTQKKNSVTYSCCPEAYEDVEVSLNFRKKG 
              EEE_B__EEE____B_   _B___EEEEEEEEE__ 
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BMC Structural Biology 2002, 2 http://www.biomedcentral.com/1472-6807/2/1liability and other undesirable side-effects of nicotine pro-
hibit the use of this natural product for therapeutic appli-
cations, but the active development of nAChR agonists
presenting adequate receptor subtype specificity should
result in improved pharmacology and potency [4]. As for
most membrane proteins, information on the 3 dimen-
sional structure of the nAChR is limited, and the best ex-
perimental structure consists of 4.6 A data from electron
microscopy [5], a resolution that does not allow for struc-
ture-based design approaches.
Recently, Sixma and colleagues have determined the first
high-resolution structure of a soluble acetylcholine bind-
ing protein (AChBP), extracted from snail neurons, and
homologous to the ligand binding domain of nAChR [6].
Based on this high-resolution crystal structure, we have
built an atomic model of the agonist binding site of
nAChR, and docked acetylcholine and nicotine to differ-
ent receptor isotypes. The resulting models provide a val-
uable framework for structure-based design of subtype-
specific nAChR agonists.
Results and Discussion
The crystal structure of two consecutive AChBP mono-
mers [6] was used as a template to build a homology-
model of four known native human nAChR subunit inter-
faces: alpha4-beta2 (I1), alpha4-beta4 (I2), alpha3-beta2
(I3), and alpha7-alpha7 (I4). The corresponding first two
nAChR subtypes are possibly involved in cognition, neu-
rodegeneration, pain, anxiety and depression, while
alpha3-beta2 nAChR is associated with dopamine release
and addiction, and alpha7-alpha7 with GABA release [4].
First, the sequences of the five nAChR monomers (alpha3,
alpha4, alpha7, beta2 and beta4) were aligned to AChBP
in a multi-protein sequence alignment. The alignment
was generated automatically by the ICM method and ad-
justed manually around residues 188–208, to align an in-
sertion in human nAChR subunits with a loop region of
the 3D template (Figure 1).
Based on the sequence alignment, the query sequences
where threaded onto the first two subunits of the AChBP
pentamer. A disulfide bridge (the so-called cys-loop),
present only in the alpha subunits of nAChR, is known to
be part of the agonist binding site of the receptor [7]. This
was a clear indication that, in order to build a dimer inter-
face that includes the ligand binding pocket, alpha subu-
nits had to be aligned onto the template monomer
presenting a disulfide bridge at the interface (subunit 1).
A putative HEPES (N-2 hydroxyethylpiperazine-N'-2-
ethanesulphonic acid) molecule is present in the binding
pocket of the template structure. All residues in the close
vicinity of this ligand were confirmed experimentally as
being part of the acetylcholine binding pocket [6]. While
the homology between AChBP and the nAChR subunits is
relatively low (22 % sequence identity, for instance, be-
tween alpha4 and AChBP), and the overall model needs
to be refined, 72% of the AChBP residues in contact with
HEPES are identical in the alpha4-beta2 nAChR (Figure
1), and the predicted conformation of the agonist binding
pocket of nAChR is expected to be accurate. In order to op-
timize the conformation of this pocket, all residues within
7A of the HEPES molecule that were not identical between
template and model were energy-minimized in the inter-
nal coordinate space [8]. The resulting models were used
for docking experiments.
Both acetylcholine and nicotine were docked to our mod-
el of the alpha4-beta2 dimer interface. A formal charge of
+1 was assigned to the quaternary ammonium group of
acetylcholine and protonated nicotine. Indeed, a correla-
tion between EC50 values and quantum mechanics simu-
lations strongly suggests the existence of a cation-pi
interaction between a triptophan residue of the ligand
binding pocket and the quaternary ammonium of acetyl-
choline [9]. A series of grid representations of the ligand
binding pocket was generated that accounted for Van der
Waals shape, electrostatic potential, as well as hydrogen
bonding and hydrophobicity profiles. The flexible ligands
were rapidly docked into the superimposed grids, and the
lowest energy conformation was further refined with an
atomic representation of the receptor, and with both lig-
and and receptor side chains flexible [10] (see "Materials
and Methods" for details).
Figure 2
Acetylcholine (space filling representation) docked into the
agonist binding pocket of human nAChR, at the interface of
the alpha4 (subunit 1) and beta2 (subunit 2) monomers.
Gold: alpha4, cyan: beta2, yellow: ligand binding site. Other
interfaces modeled in this study are also indicated.Page 3 of 8
(page number not for citation purposes)
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the alpha4-beta2 interface of nAChR (Figure 2). This
binding site coincides with that of AChBP, and is in agree-
ment with photo-affinity labeling and mutagenesis study
[6,11]. The ligand makes Van der Waals contact with
Trp182, Tyr230 and Cys225-226 of alpha4, and Trp82,
Leu146 and Phe144 of beta2 (Figure 3 – Top). The
charged ammonium nitrogen is closest to the side-chain
of alpha4 Trp182. This is in agreement with previous work
assigning a cation-pi interaction between acetylcholine
and this residue exclusively [9]. The carbonyl oxygen of
acetylcholine and backbone nitrogen of Leul46 are also
engaged in a hydrogen bond. Interestingly, a small polar
cleft next to this oxygen could accommodate a water mol-
ecule coordinated by two hydrogen bond donors -alpha4
Trp182 indole nitrogen and beta2 Leu146 amide nitro-
gen- and one hydrogen bond acceptor -beta2 Ser133 car-
bonyl (Figure 3 – Left). This water molecule would form
an additional hydrogen bond with acetylcholine, thereby
stabilizing further the predicted bound conformation.
Surprisingly, the ester moiety of acetylcholine does not
seem to interact with the cys-loop of the receptor, as pre-
viously suggested by photoaffinity labeling [12], but is en-
gaged in similar type of interaction as that observed with
the acidic group of HEPES in the AChBP crystal structure
[6]. It is possible that the reactive di-azo group of the pho-
tosensitive agonist used in photoaffinity labeling would
extend towards the cys-loop, while the conformation of
the bound agonist remains in agreement with our model.
Nicotine makes Van Der Waals contacts with the same ar-
ray of receptor side-chains (Figure 3 – Bottom). The pro-
tonated ammonium nitrogen is also making polar
interaction with the delocalized electron and backbone
carbonyl of Trp182, and is less than 1A away from the
quaternary nitrogen of docked acetylcholine. Additional-
ly, a hydrogen bond between the pyridine nitrogen of nic-
otine and indole nitrogen of Trp182 is possible (the two
atoms are 3.4 A apart), but the bond angle is not optimal
(70 degrees with the plane of the aromatic side-chain). In-
terestingly, while two conformations appear with equal
probability when the docking is performed without the
water molecule positioned in the acetylcholine complex,
addition of this water molecule results in an extra hydro-
gen bond with the pyridine nitrogen of nicotine, and sta-
bilizes the conformation presented (Figure 3 – Bottom).
In the alternative, less energetically favorable conforma-
tion, nicotine contacts mostly subunit alpha4, plus
Leu146 and Trp82 of beta2 (data not shown).
Similarly, acetylcholine and nicotine were docked into the
agonist binding site at the alpha3-beta2, alpha4-beta4
and alpha7-alpha7 interfaces. The ligands adopted similar
conformation as docked to alpha4-beta2. Four residues in
the vicinity of the ligands are varying from one receptor
isotype to the other: Thr183 of alpha4 (Ser in alpha3 and
alpha7), Ala135 of beta2 (Leu in beta4 and Val in
alpha7), Phe144 of beta2 (Leu in beta4 and Gln in
alpha7), and Thr83 of beta2 (Lys in beta4 and Gln in
alpha7) (Figure 1). Neither a threonine, nor a serine at po-
sition 183 of subunit 1 contact the ligands. On the other
hand, while Ala135 is 8.5A away from the docked ago-
nists, a leucine could make some hydrophobic interaction
with nicotine and acetylcholine. The side-chain of Phe144
contacts the ligands only via its c-alpha an c-beta atoms,
and similar interaction can occur with a leucine or
glutamine at this position; however, while the conforma-
tion presented is projecting away from the ligands, alter-
native conformers could bring the side-chain closer to the
agonists, and represent structural determinants for specif-
Figure 3
Acetylcholine (top) and nicotine (bottom) docked to the
agonist binding site of human nAChR alpha4-beta2. Left: the
ligands would form a polar interaction with the delocalized
electron of Trp182, and with a water molecule (green) coor-
dinated by Trp182, Leu146 and Ser133. Right: space filling
representation shows how the ligands occupy the binding
pocket (yellow). Color coding is magenta: ligand, gold: subu-
nit alpha4, cyan: subunit beta2, blue: nitrogen, red: oxygen,
yellow: sulfur. Most hydrogen atoms (gray) are not shown
for clarity.Page 4 of 8
(page number not for citation purposes)
BMC Structural Biology 2002, 2 http://www.biomedcentral.com/1472-6807/2/1icity. At last, beta-2 Thr83 is rather remote from the lig-
ands (8.5 A), but the side-chain of a lysine could come
closer and influence lightly the electrostatic potential of
the binding cavity.
Based on our models, we calculated the binding energy of
acetylcholine and nicotine to the four receptor isotypes in
the presence of the water molecule (Table 1 – top). The
binding energy function, previously validated against a di-
versified benchmark [20], includes a hydrophobic term,
an electrostatic term, and an entropic term, but does not
include Van der Waals energy, since this term is too noisy;
Van der Waals interactions are supposed to be proportion-
al to the interface of the interacting molecules, and incor-
porated into the surface (hydrophobic) term (see
Materials and Methods). As a result, the binding energy
function has an accuracy of 2.5 kcal/mol, but does not ac-
count for potential Van der Waals clashes. The Van der
Waals interaction energies were calculated separately, and
are also presented.
Table 1 shows that binding energy differences between the
two ligands and the four nAChR subtypes are rather small,
and within the 2.5 kcal/mol accuracy of the estimates
[20]. As expected, no Van der Waals clash is observed. The
calculated energies suggest a lower affinity of nicotine for
alpha7-alpha7 than for alpha4-beta2, which is in agree-
ment with experiments [3]. The ligands were also docked
to the crystal structure of AChBP (the binding conforma-
tion was identical as with nAChRs), and the binding ener-
gies calculated. Again, the predicted energies of
acetylcholine and nicotine binding to AChBP are close to
those for binding to nAChRs (Table 1 – top). We also
docked HEPES to the receptors, since this ligand was
found in the crystal structure of AChBP. Low-energy con-
formations were found only in the absence of water mol-
ecule, and the calculated binding energies (Table 1 –
bottom) suggest that HEPES is a poor ligand for nAChRs,
and AChBP, and was observed in the crystal structure be-
cause of its high concentration (100 mM) in the crystalli-
zation condition [6].
The presence of the isotype diversity of nAChR ligand
binding pocket should allow for the rational design of se-
lective agonists. Variations at residues alpha4 Thr183 and
beta2 Ala135 generate different shapes of the binding
pocket (Figure 4 – Top), but preserve the electrostatic po-
tential of the system: all non-conserved residues at posi-
tion 183 are hydrophobic, and hydroxyl of Thr154 and
Ser154 are superimposed, pointing away from the ligand,
towards the carboxylate of Asp122. On the other hand,
variations at residues 83 and 144 of subunit 2 can modify
lightly the charge distribution of the binding site. Color-
ing of the pocket according to its electrostatic potential
shows for instance that the alpha7-alpha7 pocket is slight-
ly more electronegative than alpha4-beta2 (Figure 4 – Bot-
tom). However, these variations are rather limited and the
agonist binding site remains electronegative for all iso-
types tested.
In order to illustrate how, based on our models, a high af-
finity ligand can be rationally designed to be specific for
beta2-containing nAChR subtypes, we searched a data-
base of over 200,000 compounds (ChemDiv Inc., San Di-
ego, CA), for alpha4-beta2 ligand candidates presenting a
functional group close to Ala 135 of the beta2 subunit,
Table 1: Predicted binding energies (in kcal/mol) derived from the models of nAChR-agonist complexes. 
Receptor Acetylcholine Nicotine
Alpha4-Beta2-H2O -5.31/-22.5 -6.02/-6.3
Alpha4-Beta4-H2O -3.86/-10.0 -4.62/-17.6
Alpha3-Beta2-H2O -6.0/-13.2 -6.71/-18.9
Alpha7-Alpha7-H2O -3.61/-22.8 -4.2/-7.2
AChBP-H2O -5.8/-9.1 -6.25/-19.3
Receptor 1 HEPES
Alpha4-Beta2 -10.2/7.8 -0.6/-21.3
Alpha4-Beta4 -8.3/144.8 0.1/-2.2
Alpha3-Beta2 -10.3/5.3 -0.8/-17.5
Alpha7-Alpha7 -9.5/103.6 0.1/-21.7
AChBP -9.4/47.7 -2.00/-29.2
For each complex: left term = binding energy, right term = Van der Waals energy of interaction. Top: Binding energies of acetylcholine and nicotine in 
the presence of the water molecule shown figure 3. Bottom: Binding energies of 1 and HEPES without water molecule.Page 5 of 8
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BMC Structural Biology 2002, 2 http://www.biomedcentral.com/1472-6807/2/1hoping that such functional group could not accommo-
date the bulkier Leu 135 of beta4 (Figure 4 – Top). Each
compound of the database was docked in the grid poten-
tial representation of the alpha4-beta2 receptor (without
a water molecule), and assigned a score reflecting the
quality of the fit, as implemented in the ICM-VLS module
(Molsoft LLC, San Diego, CA). The top scoring com-
pounds were considered as good ligand candidates and
were screened with two additional filters.
1) They should present a functional group within 5 A of
beta2 Ala135. 2) They should have a polar group that fills
the cavity occupied by water in the nicotine and acetylcho-
line complexes, and that makes hydrogen bonds similar
to the water molecule (Figure 3 – Left). We believe this
second filter should result in the identification of im-
proved pharmacophores for nAChR ligands.
Molecule 1 is one good candidate that matches all criteria
(Figure 5A).
1) It is the 16th best scoring compound, and displays bet-
ter calculated binding energies than acetylcholine or nico-
tine for alpha4-beta2 nAChR (Table 1 – Bottom).
2) It presents a pyridine in the vicinity of beta2-Ala135,
which clashes with the corresponding Leu 135 of beta4
(Figures 5B and 5D).
 3) It displays an amide group that occupies a cavity not
filled by nicotine or acetylcholine, and makes a network
of hydrogen bonds with the indole nitrogen of alpha4-
Trp182, the backbone carbonyl of beta2-Ser133 and
beta2-Phe144, and with the backbone nitrogen of beta2-
Leu146 (Figure 5B).
To address further the specificity of this ligand candidate,
we docked it, as previously described, to the other three
nAChRs subtypes studied in this work, as well as to the
crystal structure of AChBP, and calculated the correspond-
ing binding energies (Table 1 bottom). In all cases, the
predicted binding energies are better than for nicotine or
acetylcholine. The calculated Van der Waals repulsions
with alpha4-beta2 and alpha3-beta2 nAChRs remain
small, and within the accuracy limit of Van der Waals en-
ergy prediction (the otherwise negligible displacement of
an atom by a tenth of an Angstrom may result in several
kcal/mol energy difference). On the other hand, the very
high Van der Waals repulsions calculated Table 1 (bot-
tom) for alpha4-beta4 and alpha7-alpha7 are a clear indi-
cation of a steric clash (Figure 5D): the ligand fits next to
Ala 135 of beta2, but cannot accommodate Leu 135 of
beta4.
Conclusions
Previous reports have shown on other systems that a sin-
gle-residue mutation in a receptor is sufficient for the de-
velopment of specific ligands [13,14]. Based on the recent
crystal structure of AChBP, we could propose a detailed
description of the structural variations of nAChR sub-
types. Our models of the nAChRs binding pocket are only
predictive, and need to be confirmed experimentally; test-
ing in vitro the activity of ligand candidates, such as 1, de-
rived from the structure of the receptor would constitute
an important first step towards the validation of our mod-
els as tools for the discovery of novel nAChR agonists.
Figure 4
Structural determinants for receptor subtype specificity.
Top: Two non-conserved residues provide structural diver-
sity to the ligand binding site (left: alpha4-beta2, center:
alpha4-beta4, right: alpha7-alpha7). The shape difference of
the Van der Waals boundary is shown at residue 183 of sub-
unit 1 (gold), and 135 of subunit 2 (cyan), next to docked nic-
otine (magenta). Bottom: Electrostatic potential coloring
shows a rather limited variation in charge distribution
between the alpha4-beta2 dimer (left) and the alpha7-alpha7
dimer (right). Charge color coding is red: negative, gray:
hydrophobic, blue: positive.Page 6 of 8
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Multiple Sequence Alignment
The sequences of AChBP, and of the alpha3, alpha4,
alpha7, beta2 and beta4 nAChR monomers were aligned
using the ICM multiple sequence alignment algorithm
that includes the following steps [16,10]: 1) pairwise
alignment using Needleman and Wunsch algorithm mod-
ified to use zero end gap penalties (so called ZEGA)
[15,16]. 2) evolutionary tree construction with a "neigh-
bor-joining algorithm" to determine the order of align-
ment and calculate relative weights of sequences and
profiles from the branch lengths [17]. 3) traverse the tree
from top to bottom, aligning the closest sequences or pro-
files.
3D Model Building of nAChRs Subunit Interface
For each nAChR dimer, two monomer sequences were
threaded onto two consecutive subunits of the AChBP
crystal structure, based on the multiple sequence align-
ment, and the energy of the system was locally minimized
by the ICM method [10,18]. The orientation of all polar
hydrogens was systematically optimized through confor-
mational space search combined with local minimiza-
tion. All nAChR residues within 7A of the putative AChBP
binding pocket described by Brejc et al. [6] that differed
from the AChBP template residue were energy-minimized
in the internal coordinates space using ICM global confor-
mational search algorithm. Energy terms included Van der
Waals, electrostatic, hydrogen bond, and torsion terms
[10].
Receptor-Ligand Docking
The flexible ligand / grid receptor docking algorithm im-
plemented in ICM was applied, with ECEPP/3 force field
and MMFF partial charges for the ligand, and hydropho-
bic, electrostatic, hydrogen-bond and surface potential
maps for the receptor [18,19,10]. Further optimization
with flexible ligand and full atom representation of the re-
ceptor was carried out by local energy minimization,
where all side-chains within 6 A of the ligand were flexible
[18]. When docking was performed in the presence of a
water molecule, the later was included in the grid repre-
sentation of the receptor, and was mobile during full-
atom local minimization.
Binding Energy Calculation
The binding energy function implemented in icm is parti-
tioned into three terms: the hydrophobic, or cavity term,
that accounts for the variation of water/non-water inter-
face area, the electrostatic term, composed of the coulom-
bic interactions and desolvation of partial charges
calculated by the boundary elements method, and the en-
tropic term, that results from the decrease in the confor-
mational freedom of functional groups buried upon
complexation [20]. A constant term also present in the en-
ergy function, that accounts for the change of entropy of
the system due to the decrease of free molecules concen-
tration and the loss of rotational/translational degrees of
freedom, was omitted, and only differences in the binding
energies of the ligands are accurate. The dielectric constant
and surface tension utilized were optimized against a
benchmark of eight protein-protein, 13 protein-small lig-
and, and eight protein-peptide complexes, and result in a
2.5 kcal/mol accuracy [20].
Figure 5
Candidate nAChR agonist, specific for beta2-containing sub-
types. A: Chemical structure of 1. B: Details of the interac-
tions between 1 (gray) and alpha4-beta2 nAChR agonist
binding pocket (gold: alpha4, cyan: beta2). 1 occupies the
same pocket as docked nicotine (magenta), and presents a
pyridine extension (circled in black) that fits next to Ala 135
of beta-2, but clashes with Leu 135 of beta-4 (white), or Val
135 of alpha-7 (not shown). An amide group of 1 fills the
pocket occupied by a water molecule when nicotine or ace-
tylcholine are bound (Figure 3 – Left) and makes a network
of hydrogen-bonds (black lines) with the receptor.C: Same
view and orientation as in B, with a skin representation of the
binding pocket.D: Same as C, with alpha4-beta4 nAChR
binding pocket: the steric clash between the receptor and
the pyridine moiety of the ligand is visible.
A B
C D
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Virtual Library Screening
The high-throughput docking implemented in the ICM
program [10] was applied. The procedure followed for
each ligand was similar than the grid docking previously
described [21]: each flexible ligand of the ChemDiv pub-
lic library (ChemDiv Inc., San Diego) was docked auto-
matically into the combination of potential maps
described above, and assigned a score according to its fit
with the alpha4-beta2 nAChR. The scoring function in-
cluded continuum as well as discreet electrostatics, hydro-
phobicity and entropy parameters. The screening of the
database of over 200,000 ligands took less than 2 days on
a Linux cluster of 150 processors. The 3003 compounds
which scored better (i.e. lower) than -35 were pre-selected
for a second automatic round of selection: only ligands
within 5 A of Ala 135 of the beta-2 subunit and that were
hydrogen-bonded to the carbonyl oxygen of beta-2 Ser
133 were retained. 1 was among the best scoring such
compounds after this second round of selection.
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